Information letter No. 01I-1468/21 of 09.11.2021 on introduction of new safety info into the instruction for use of the drug Baeta® (INN – Exenatide)

2021-11-23T13:34:52+03:00

New data on the efficacy and safety of the drug were obtained, therefore significant changes were made to the Instructions for Medical Use (SMPC), including the sections Pharmacodynamics, Pharmacokinetics, Indications for use, Use during pregnancy and breastfeeding, Dosage and administration, Side effects, Overdose, Interaction with other drugs, Special Precautions, the section "Effect on the ability [...]